Recent Finacing
Recent Raise
Pliant Therapeutics is a clinical-stage biopharma developing tissue-specific small-molecule integrin inhibitors (αVβ1/αVβ6) to block TGF-β activation and treat multi-organ fibrotic diseases; lead drug PLN-74809 in Phase 2a.
